Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease

被引:109
作者
Bijvoet, AGA
van de Kamp, EHM
Kroos, MA
Ding, JH
Yang, BZ
Visser, P
Bakker, CE
Verbeet, MP
Oostra, BA
Reuser, AJJ
van der Ploeg, AT
机构
[1] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands
[3] Sophia Childrens Univ Hosp, Dept Paediat, NL-3000 CB Rotterdam, Netherlands
[4] Duke Univ, Med Ctr, Dept Pediat, Div Genet & Metab, Durham, NC 27709 USA
[5] Leiden Univ, Leiden Inst Chem, Metalloprot & Prot Engn Grp, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1093/hmg/7.1.53
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycogen storage disease type II (GSDII; Pompe disease), caused by inherited deficiency of acid alpha-glucosidase, is a lysosomal disorder affecting heart and skeletal muscles, A mouse model of this disease was obtained by targeted disruption of the murine acid alpha-glucosidase gene (Gaa) in embryonic stem cells. Homozygous knockout mice (Gaa -/-) lack Gaa mRNA and have a virtually complete acid alpha-glucosidase deficiency, Glycogen-containing lysosomes are detected soon after birth in liver, heart and skeletal muscle cells, By 13 weeks of age, large focal deposits of glycogen have formed, Vacuolar spaces stain positive for acid phosphatase as a sign of lysosomal pathology, Both male and female knockout mice are fertile and can be intercrossed to produce progeny The first born knockout mice are at present 9 months old, Overt clinical symptoms are still absent, but the heart is typically enlarged and the electrocardiogram is abnormal, The mouse model will help greatly to understand the pathogenic mechanism of GSDII and is a valuable instrument to explore the efficacy of different therapeutic interventions.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 43 条
  • [1] BAKKER CE, 1994, CELL, V78, P23
  • [2] Expression of cDNA-encoded human acid alpha-glucosidase in milk of transgenic mice
    Bijvoet, AGA
    Kroos, MA
    Pieper, FR
    DeBoer, HA
    Reuser, AJJ
    VanderPloeg, AT
    Verbeet, MP
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1996, 1308 (02): : 93 - 96
  • [3] CARDIFF RD, 1966, PEDIATRICS, V37, P249
  • [4] REQUIREMENT FOR A FUNCTIONAL RB-1 GENE IN MURINE DEVELOPMENT
    CLARKE, AR
    MAANDAG, ER
    VANROON, M
    VANDERLUGT, NMT
    VANDERVALK, M
    HOOPER, ML
    BERNS, A
    RIELE, HT
    [J]. NATURE, 1992, 359 (6393) : 328 - 330
  • [5] OBSERVATIONS ON CARDIAC GLYCOGEN IN SPONTANEOUS ROUND HEART-DISEASE
    CZARNECKI, CM
    JANKUS, EF
    [J]. AVIAN DISEASES, 1974, 18 (04) : 614 - 618
  • [6] GLYCOGEN, ITS CHEMISTRY AND MORPHOLOGIC APPEARANCE IN ELECTRON-MICROSCOPE .1. MODIFIED OSO4 FIXATIVE WHICH SELECTIVELY CONTRASTS GLYCOGEN
    DEBRUIJN, WC
    [J]. JOURNAL OF ULTRASTRUCTURE RESEARCH, 1973, 42 (1-2): : 29 - 50
  • [7] COTRANSFER OF SYNTENIC HUMAN GENES INTO MOUSE CELLS USING ISOLATED METAPHASE CHROMOSOMES OR CELLULAR DNA
    DEJONGE, AJR
    DESMIT, S
    KROOS, MA
    REUSER, AJJ
    [J]. HUMAN GENETICS, 1985, 69 (01) : 32 - 38
  • [8] Ding J. H., 1994, American Journal of Human Genetics, V55, pA325
  • [9] SPECTRUM AND DIAGNOSIS OF ACID MALTASE DEFICIENCY
    ENGEL, AG
    GOMEZ, MR
    SEYBOLD, ME
    LAMBER, EH
    [J]. NEUROLOGY, 1973, 23 (01) : 95 - 106